rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1995-5-22
|
pubmed:abstractText |
The authors previously conducted a pilot, dose-escalating study which suggested that a 20-micrograms dose of intravitreal cidofovir (HPMPC) may be safe and effective in treating cytomegalovirus (CMV) retinitis in humans. The purpose of this series is to expand the authors' prior experience with the 20-micrograms dose of cidofovir as the sole treatment for CMV retinitis in patients with acquired immune deficiency syndrome.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0161-6420
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
533-42; discussion 542-3
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7724170-AIDS-Related Opportunistic Infections,
pubmed-meshheading:7724170-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:7724170-Adult,
pubmed-meshheading:7724170-Antiviral Agents,
pubmed-meshheading:7724170-Ciliary Body,
pubmed-meshheading:7724170-Cytomegalovirus Retinitis,
pubmed-meshheading:7724170-Cytosine,
pubmed-meshheading:7724170-Drug Therapy, Combination,
pubmed-meshheading:7724170-Female,
pubmed-meshheading:7724170-Humans,
pubmed-meshheading:7724170-Injections,
pubmed-meshheading:7724170-Intraocular Pressure,
pubmed-meshheading:7724170-Male,
pubmed-meshheading:7724170-Middle Aged,
pubmed-meshheading:7724170-Organophosphorus Compounds,
pubmed-meshheading:7724170-Phosphonic Acids,
pubmed-meshheading:7724170-Probenecid,
pubmed-meshheading:7724170-Retina,
pubmed-meshheading:7724170-Uveitis,
pubmed-meshheading:7724170-Vitreous Body
|
pubmed:year |
1995
|
pubmed:articleTitle |
Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
|
pubmed:affiliation |
Department of Ophthalmology, Shiley Eye Center, University of California at San Diego, La Jolla 92093-0946, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|